274 related articles for article (PubMed ID: 11889593)
1. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
Helpap B; Klöppel G
Virchows Arch; 2002 Mar; 440(3):241-8. PubMed ID: 11889593
[TBL] [Abstract][Full Text] [Related]
2. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Helpap B
Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
[TBL] [Abstract][Full Text] [Related]
3. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.
Hailemariam S; Gaspert A; Komminoth P; Tamboli P; Amin M
Mod Pathol; 1998 Oct; 11(10):1016-20. PubMed ID: 9796733
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.
Mascolo M; Altieri V; Mignogna C; Napodano G; De Rosa G; Insabato L
BMC Cancer; 2005 Jul; 5():88. PubMed ID: 16048646
[TBL] [Abstract][Full Text] [Related]
5. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.
Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E
Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193
[TBL] [Abstract][Full Text] [Related]
6. Large cell neuroendocrine carcinoma of the urinary bladder. Bibliographic review.
Martín IJ; Vilar DG; Aguado JM; Perelló CG; Aliaga MR; Argente VG; Ferreres LA; Gómez JG
Arch Esp Urol; 2011 Mar; 64(2):105-13. PubMed ID: 21399243
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine differentiation of bladder tumors].
Vincendeau S; de Lajarte-Thirouard AS; Bensalah K; Guillé F; Lobel B; Patard JJ
Prog Urol; 2003 Jun; 13(3):375-84. PubMed ID: 12940189
[TBL] [Abstract][Full Text] [Related]
9. "Pure" primary large cell neuroendocrine carcinoma of the urinary bladder: case report, literature review and diagnostic criteria.
Pusiol T; Morichetti D; Zorzi MG
Pathologica; 2014 Jun; 106(2):82-5. PubMed ID: 25291874
[TBL] [Abstract][Full Text] [Related]
10. Large cell neuroendocrine carcinoma of urinary bladder; case presentation.
Sari A; Ermete M; Sadullahoğlu C; Bal K; Bolükbaşi A
Turk Patoloji Derg; 2013; 29(2):138-42. PubMed ID: 23661352
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the prostate].
Bours AF; Jorion JL; Donnay M; Ledent G; Van Ruyssevelt C
Acta Urol Belg; 1993 Sep; 61(3):13-6. PubMed ID: 8256680
[TBL] [Abstract][Full Text] [Related]
12. [Primary neuroendocrine carcinoma of the bladder: diagnosis and treatment].
Karmouni T; Rioux-Leclercq N; Bensalah K; Alva A; Patard JJ; Guillé F; Lobel B
Prog Urol; 2000 Sep; 10(4):590-4. PubMed ID: 11064903
[TBL] [Abstract][Full Text] [Related]
13. Primary large cell neuroendocrine carcinoma of the urinary bladder.
Lee KH; Ryu SB; Lee MC; Park CS; Juhng SW; Choi C
Pathol Int; 2006 Nov; 56(11):688-93. PubMed ID: 17040293
[TBL] [Abstract][Full Text] [Related]
14. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
15. How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder?
Vakar-Lopez F; True LD
Am J Clin Pathol; 2007 Nov; 128(5):723-5. PubMed ID: 17951191
[No Abstract] [Full Text] [Related]
16. Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy.
Zhao X; Flynn EA
Arch Pathol Lab Med; 2012 Nov; 136(11):1451-9. PubMed ID: 23106592
[TBL] [Abstract][Full Text] [Related]
17. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
18. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
[TBL] [Abstract][Full Text] [Related]
19. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in early prostatic cancer.
Gorgoulis VG; Tiniakos DG; Mariatos G; Manolis EN; Mitropoulos D; Kittas C
Anticancer Res; 1999; 19(3B):2327-48. PubMed ID: 10472353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
